tsoledronihappo hameln 4 mg / 5 ml infuusiokonsentraatti, liuosta varten
hameln pharma gmbh - zoledronic acid monohydrate - infuusiokonsentraatti, liuosta varten - 4 mg / 5 ml - tsoledronihappo
tabrecta
novartis europharm limited - capmatinib dihydrochloride monohydrate - karsinooma, ei-pienisoluinen keuhko - antineoplastiset aineet - tabrecta as monotherapy is indicated for the treatment of adult patients with advanced non small cell lung cancer (nsclc) harbouring alterations leading to mesenchymal epithelial transition factor gene exon 14 (metex14) skipping, who require systemic therapy following prior treatment with immunotherapy and/or platinum based chemotherapy.
seroquel 25 mg tabletti, kalvopäällysteinen
astrazeneca oy - quetiapine fumarate - tabletti, kalvopäällysteinen - 25 mg - ketiapiini
seroquel 100 mg tabletti, kalvopäällysteinen
astrazeneca oy - quetiapine fumarate - tabletti, kalvopäällysteinen - 100 mg - ketiapiini
seroquel 200 mg tabletti, kalvopäällysteinen
astrazeneca oy - quetiapine fumarate - tabletti, kalvopäällysteinen - 200 mg - ketiapiini
seroquel 150 mg tabletti, kalvopäällysteinen
astrazeneca oy - quetiapine fumarate - tabletti, kalvopäällysteinen - 150 mg - ketiapiini
seroquel 300 mg tabletti, kalvopäällysteinen
astrazeneca oy - quetiapine fumarate - tabletti, kalvopäällysteinen - 300 mg - ketiapiini
seroquel prolong 50 mg depottabletti
astrazeneca oy - quetiapine fumarate - depottabletti - 50 mg - ketiapiini
seroquel prolong 200 mg depottabletti
astrazeneca oy - quetiapine fumarate - depottabletti - 200 mg - ketiapiini
seroquel prolong 300 mg depottabletti
astrazeneca oy - quetiapine fumarate - depottabletti - 300 mg - ketiapiini